113 results
Page 5 of 6
6-K
EX-99.2
m3j2zfof7 9o45
7 Nov 19
Index to Condensed Consolidated Financial Statements
4:28pm
6-K
EX-99.2
hlgc6r
8 Aug 19
Index to Condensed Consolidated Financial Statements
4:36pm
424B5
pv3mbs
24 Jul 19
Prospectus supplement for primary offering
4:20pm
F-3
9wlous u03tciv0a
17 Jul 19
Shelf registration (foreign)
5:15pm
6-K
EX-99.2
tab6f5
14 May 19
Index to Condensed Consolidated Financial Statements
4:32pm
424B4
cwt6y46l
11 Apr 19
Prospectus supplement with pricing info
4:10pm
6-K
dct c97owtnks2
8 Apr 19
Autolus Announces Proposed Public Offering in the United States
5:30pm
F-1
jwmuunbtx25d xce
8 Apr 19
Registration statement (foreign)
4:34pm
6-K
EX-99.1
ulif4gossvynbmihc
2 Apr 19
Initial Results from Autolus Therapeutics’ ALLCAR19 Phase 1/2 Trial in Adult
7:52am
6-K
EX-99.2
iqx26
2 Apr 19
Initial Results from Autolus Therapeutics’ ALLCAR19 Phase 1/2 Trial in Adult
7:52am
6-K
EX-99.1
3dox 7xzt47al
27 Mar 19
Autolus Therapeutics Unveils Expanded Next Generation Technology and Pipeline and Provides Key Update on AUTO3 Program in Pediatric ALL at R&D Day
4:04pm
6-K
EX-1
70nyh
15 Mar 19
Annual Report and Accounts
5:26pm
6-K
EX-99.1
205d6kivfksnq8
25 Feb 19
Current report (foreign)
4:39pm
6-K
EX-99.1
etp6e4kqy fm
3 Dec 18
Autolus Therapeutics Presents Initial AUTO3 Clinical Data from Phase 1/2
9:15pm
6-K
EX-99.2
e69iam1hqvsg5c9jcvf
3 Dec 18
Autolus Therapeutics Presents Initial AUTO3 Clinical Data from Phase 1/2
9:15pm
20-F
ulg6z
23 Nov 18
Annual report (foreign)
12:00am
DRS
kj1n0v4tv 6g
23 Nov 18
Draft registration statement
12:00am
S-8
EX-4.1
dby5xxvojxoq6im2
31 Jul 18
Registration of securities for employees
4:09pm
424B4
6wpbwr3cbtk2ao
22 Jun 18
Prospectus supplement with pricing info
4:02pm